This blog article gives providers guidance on sickle cell and thalassaemia screening for women who are pregnant via egg donation.
Duljeet has been Haemoglobinopathy Lead Scientist at UK National External Quality Assurance Scheme since 2017. She trained as a biomedical scientist at Hammersmith Hospital before moving to NEQAS. Outside work she enjoys boxing.
Related content and links
The PHE Screening team
Public Health England (PHE) existed to protect and improve the nation’s health and wellbeing, and reduce health inequalities. It closed on 30 September 2021 and this blog is no longer updated.
Find out more about the implications for health screening in our Changes ahead for the national screening system blog article.
If you want to stay in touch with screening evidence and policy news, you can subscribe to the UK National Screening Committee blog.
Comments and moderation
- Changes ahead for the national screening system 30 September 2021
- What we blogged about in August and September 2021 30 September 2021
- New resources to help improve quality of samples taken in NHS newborn blood spot screening 30 September 2021